LIDDS
0.13 SEK 0%1 investor is following this company
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patent-protected and clinically tested drug delivery technology. The properties of the products form the basis of LIDDS 'technology platform for the development of injectable drug products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System and the company is headquartered in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
LIDDS
Daily low / high price
0.129 / 0.13
SEK
Market cap
17.74M SEK
Turnover
8.5K SEK
Volume
65K
Financial calendar
Interim report
28.08.2024
Interim report
21.11.2024
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 13.4 % | 13.4 % |
Wikow Venture | 6.1 % | 6.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Bulletin from the Annual General Meeting in LIDDS AB (PUBL) on 27 May 2024
LIDDS moves the publication of the Interim Report for the first quarter 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools